Annual EBIT:
-$45.62M-$20.42M(-81.04%)Summary
- As of today, KNSA annual earnings before interest & taxes is -$45.62 million, with the most recent change of -$20.42 million (-81.04%) on December 31, 2024.
- During the last 3 years, KNSA annual EBIT has risen by +$111.02 million (+70.88%).
- KNSA annual EBIT is now -566.76% below its all-time high of $9.77 million, reached on December 31, 2022.
Performance
KNSA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$20.16M+$6.89M(+51.90%)Summary
- As of today, KNSA quarterly earnings before interest & taxes is $20.16 million, with the most recent change of +$6.89 million (+51.90%) on June 30, 2025.
- Over the past year, KNSA quarterly EBIT has increased by +$20.28 million (+17330.77%).
- KNSA quarterly EBIT is now -56.56% below its all-time high of $46.41 million, reached on September 30, 2022.
Performance
KNSA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$4.47M+$20.28M(+128.32%)Summary
- As of today, KNSA TTM earnings before interest & taxes is $4.47 million, with the most recent change of +$20.28 million (+128.32%) on June 30, 2025.
- Over the past year, KNSA TTM EBIT has increased by +$31.98 million (+116.27%).
- KNSA TTM EBIT is now -88.26% below its all-time high of $38.11 million, reached on June 30, 2023.
Performance
KNSA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
KNSA EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | -81.0% | +10000.0% | +116.3% |
3Y3 Years | +70.9% | +204.1% | +104.1% |
5Y5 Years | +73.2% | +163.3% | +103.3% |
KNSA EBIT Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -566.8% | +70.9% | -56.6% | +204.5% | -88.3% | +109.8% |
5Y | 5-Year | -566.8% | +73.2% | -56.6% | +138.1% | -88.3% | +102.4% |
All-Time | All-Time | -566.8% | +73.2% | -56.6% | +129.8% | -88.3% | +102.4% |
KNSA EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $20.16M(+51.9%) | $4.47M(+128.3%) |
Mar 2025 | - | $13.27M(+168.8%) | -$15.80M(+65.4%) |
Dec 2024 | -$45.62M(-81.0%) | -$19.30M(-99.8%) | -$45.62M(-73.9%) |
Sep 2024 | - | -$9.66M(-8154.7%) | -$26.24M(+4.6%) |
Jun 2024 | - | -$117.00K(+99.3%) | -$27.50M(+9.9%) |
Mar 2024 | - | -$16.54M(>-9900.0%) | -$30.54M(-21.2%) |
Dec 2023 | -$25.20M(-357.8%) | $81.00K(+100.7%) | -$25.20M(-31.0%) |
Sep 2023 | - | -$10.93M(-246.4%) | -$19.23M(-150.5%) |
Jun 2023 | - | -$3.15M(+71.8%) | $38.11M(+74.1%) |
Mar 2023 | - | -$11.20M(-285.1%) | $21.90M(+124.0%) |
Dec 2022 | $9.77M(+106.2%) | $6.05M(-87.0%) | $9.77M(+130.2%) |
Sep 2022 | - | $46.41M(+339.6%) | -$32.41M(+70.4%) |
Jun 2022 | - | -$19.37M(+16.9%) | -$109.48M(+16.2%) |
Mar 2022 | - | -$23.32M(+35.5%) | -$130.67M(+16.6%) |
Dec 2021 | -$156.64M | -$36.13M(-17.8%) | -$156.64M(+9.7%) |
Sep 2021 | - | -$30.67M(+24.4%) | -$173.40M(+6.7%) |
Jun 2021 | - | -$40.55M(+17.7%) | -$185.95M(-4.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | -$49.28M(+6.8%) | -$177.26M(-12.6%) |
Dec 2020 | -$157.36M(+7.4%) | -$52.90M(-22.4%) | -$157.36M(-14.8%) |
Sep 2020 | - | -$43.22M(-35.6%) | -$137.05M(-10.3%) |
Jun 2020 | - | -$31.86M(-8.4%) | -$124.27M(+5.6%) |
Mar 2020 | - | -$29.39M(+9.8%) | -$131.70M(+22.5%) |
Dec 2019 | -$169.96M(-57.1%) | -$32.58M(-7.0%) | -$169.96M(+6.4%) |
Sep 2019 | - | -$30.45M(+22.5%) | -$181.52M(-2.4%) |
Jun 2019 | - | -$39.29M(+41.9%) | -$177.23M(-11.1%) |
Mar 2019 | - | -$67.65M(-53.3%) | -$159.47M(-47.4%) |
Dec 2018 | -$108.16M(-65.4%) | -$44.13M(-68.7%) | -$108.16M(-11.8%) |
Sep 2018 | - | -$26.16M(-21.5%) | -$96.74M(-11.4%) |
Jun 2018 | - | -$21.53M(-31.7%) | -$86.83M(-13.2%) |
Mar 2018 | - | -$16.34M(+50.0%) | -$76.69M(-17.3%) |
Dec 2017 | -$65.40M(-172.5%) | -$32.71M(-101.3%) | -$65.40M(-100.1%) |
Sep 2017 | - | -$16.25M(-42.6%) | -$32.69M(-98.8%) |
Jun 2017 | - | -$11.39M(-125.7%) | -$16.44M(-225.7%) |
Mar 2017 | - | -$5.05M | -$5.05M |
Dec 2016 | -$24.00M | - | - |
FAQ
- What is Kiniksa Pharmaceuticals International, plc annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Kiniksa Pharmaceuticals International, plc?
- What is Kiniksa Pharmaceuticals International, plc annual EBIT year-on-year change?
- What is Kiniksa Pharmaceuticals International, plc quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Kiniksa Pharmaceuticals International, plc?
- What is Kiniksa Pharmaceuticals International, plc quarterly EBIT year-on-year change?
- What is Kiniksa Pharmaceuticals International, plc TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Kiniksa Pharmaceuticals International, plc?
- What is Kiniksa Pharmaceuticals International, plc TTM EBIT year-on-year change?
What is Kiniksa Pharmaceuticals International, plc annual earnings before interest & taxes?
The current annual EBIT of KNSA is -$45.62M
What is the all-time high annual EBIT for Kiniksa Pharmaceuticals International, plc?
Kiniksa Pharmaceuticals International, plc all-time high annual earnings before interest & taxes is $9.77M
What is Kiniksa Pharmaceuticals International, plc annual EBIT year-on-year change?
Over the past year, KNSA annual earnings before interest & taxes has changed by -$20.42M (-81.04%)
What is Kiniksa Pharmaceuticals International, plc quarterly earnings before interest & taxes?
The current quarterly EBIT of KNSA is $20.16M
What is the all-time high quarterly EBIT for Kiniksa Pharmaceuticals International, plc?
Kiniksa Pharmaceuticals International, plc all-time high quarterly earnings before interest & taxes is $46.41M
What is Kiniksa Pharmaceuticals International, plc quarterly EBIT year-on-year change?
Over the past year, KNSA quarterly earnings before interest & taxes has changed by +$20.28M (+17330.77%)
What is Kiniksa Pharmaceuticals International, plc TTM earnings before interest & taxes?
The current TTM EBIT of KNSA is $4.47M
What is the all-time high TTM EBIT for Kiniksa Pharmaceuticals International, plc?
Kiniksa Pharmaceuticals International, plc all-time high TTM earnings before interest & taxes is $38.11M
What is Kiniksa Pharmaceuticals International, plc TTM EBIT year-on-year change?
Over the past year, KNSA TTM earnings before interest & taxes has changed by +$31.98M (+116.27%)